Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Columnist Ben Hofmeister remembers an Army jump and a parachute that didn't open as he reflects on how he became aware of his MS symptoms.

Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

Learn 10 key facts about multiple sclerosis, including symptoms, treatments, diagnosis, and ways to manage the condition and live well.

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Columnist Desiree Lama is learning how to manage her sensitivity to cold weather with MS now that temperatures in Texas are ...

Regular physical activity is independently linked to lower disability, fatigue, and depression in people with MS, a five-year ...

Thousands of people from dozens of countries came together in Barcelona this year for Patient Community Day 2025 at the ...

FDA has given tentative approval to Lupin’s Siponimod tablets, a bioequivalent version of Mayzent, to treat people with ...

A $1 million grant will support a study seeing if a program combining cognitive training and exercise prevents falls in older adults with MS.